Paragon 28, Inc.

    Jurisdiction
    United States
    ISIN
    US69913P1057 (FNA)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    3 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7

    Profile

    Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. Read full profile

    Fundamentals

    Net revenue
    €218.51M
    Gross margin
    75.4%
    EBIT
    -€32.89M
    EBIT margin
    -15.0%
    Net income
    -€44.76M
    Net margin
    -20.5%

    Statement period: - (published )

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Congress transactions

    Name Transaction date Value
    Josh Gottheimer March 6, 2025 $1.00K–$15.00K
    Gilbert Cisneros February 11, 2025 $1.00K–$15.00K
    Josh Gottheimer August 15, 2024 $1.00K–$15.00K

    Earnings Calls

    Earnings Calls

    Latest earnings call: May 8, 2024 (Q1 2024)

    Add to watchlist

    Notifications